The proposed University of Maryland, Baltimore (UMB) CCHI Administrative Core will be responsible for overall organization, management, decision-making, and periodic evaluation of the research projects, technology development projects, training programs, and cores within the UMB CCHI Center. The Core will also be responsible for data sharing, protection of intellectual property, and allocation of UMC CCHI resources. The main focus of the Administrative Core is successful implementation of the program goals to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases, and to maintain a stable, flexible, yet centralized infrastructure to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against these agents. The responsibilities of the CCHI Administrative Core will include, but are not limited to: 1) facilitating communications amongst the research, technology and pilot project leaders, scientific cores, and Principal Investigator;2) scheduling group meetings, and conferences;3) organizing presentations and publication of data;4) allocating and reallocating resources to meet program goals;and 5) tracking and prioritizing fiscal and other resources. A key factor in the success of any diverse program of this nature is maintaining continuous communication among the leadership team, investigators, administration, and NIH. The CCHI will interact on a daily basis to enhance communications with CCHI researchers, core leaders, and administrative and financial counterparts at all sites within the UMB CCHI. The core will also be responsible for resource sharing and transmission of information and reagents, management of the budget for programrelated travel (including travel for the annual meetings) and identifying and resolving problems and unexpected outcomes. The Core will also create and implement administrative and leadership mechanisms that will foster effective interactions among the CCHI investigators and institutions to ensure a productive research effort

Public Health Relevance

The main focus of the Administrative Core is successful implementation of the program goals to support basic and translational research on human immunological responses to NIAID Category A, B or C priority pathogens, their toxins, or other emerging or re-emerging infectious diseases, and to maintain a stable, flexible, yet centralized infrastructure to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against these agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI082655-05
Application #
8485530
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
5
Fiscal Year
2013
Total Cost
$256,096
Indirect Cost
$72,192
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Salerno-Goncalves, Rosangela; Rezwan, Tasmia; Sztein, Marcelo B (2014) B cells modulate mucosal associated invariant T cell immune responses. Front Immunol 4:511
Fiorentino, Maria; Levine, Myron M; Sztein, Marcelo B et al. (2014) Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. PLoS One 9:e85211
Waddington, Claire S; Darton, Thomas C; Jones, Claire et al. (2014) An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution. Clin Infect Dis 58:1230-40
Wahid, Rezwanul; Zafar, Shah J; McArthur, Monica A et al. (2014) Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clin Vaccine Immunol 21:427-34
McArthur, Monica A; Sztein, Marcelo B; Edelman, Robert (2013) Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert Rev Vaccines 12:933-53
Eloe-Fadrosh, Emiley A; McArthur, Monica A; Seekatz, Anna M et al. (2013) Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses. PLoS One 8:e62026
Barry, Eileen M; Pasetti, Marcela F; Sztein, Marcelo B et al. (2013) Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol 10:245-55
Eloe-Fadrosh, Emiley A; Rasko, David A (2013) The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 64:145-63
McArthur, Monica A; Sztein, Marcelo B (2013) Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol 146:140-52
Wahid, Rezwanul; Simon, Jakub K; Picking, Wendy L et al. (2013) Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. Clin Immunol 148:35-43

Showing the most recent 10 out of 24 publications